
Sign up to save your podcasts
Or


2024 trading begins after a strong market finish to 2023, with the Nasdaq 100 closing its best year since 1999. Just over 300 days before the 2024 election, former Connecticut Senator Joe Lieberman is pushing for an option outside of President Biden and President Trump. Once on the Presidential ticket himself, Lieberman started nonprofit No Labels, which hopes to offer a third, bipartisan, centrist “unity ticket” to the Americans unsatisfied with the current political playing field. Plus 2023 was the year of weight loss drugs for pharma companies like Novo Nordisk and Eli Lilly. Former FDA Commissioner Dr. Scott Gottlieb sits on the boards of Illumina and Pfizer, and he expects more good news–and more secondary benefits–from weight loss drugs on the market. Plus, Michigan is celebrating a big sports weekend, and X is now worth 71.5% less than when Elon Musk bought it, according to Fidelity, one of the co-investors that backed his takeover.
Joe Lieberman - 12:30
Dr. Scott Gottlieb - 24:46
In this episode:
Scott Gottlieb, @ScottGottliebMD
Becky Quick, @BeckyQuick
Robert Frank, @robtfrank
Michael Santoli, @michaelsantoli
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
525525 ratings
2024 trading begins after a strong market finish to 2023, with the Nasdaq 100 closing its best year since 1999. Just over 300 days before the 2024 election, former Connecticut Senator Joe Lieberman is pushing for an option outside of President Biden and President Trump. Once on the Presidential ticket himself, Lieberman started nonprofit No Labels, which hopes to offer a third, bipartisan, centrist “unity ticket” to the Americans unsatisfied with the current political playing field. Plus 2023 was the year of weight loss drugs for pharma companies like Novo Nordisk and Eli Lilly. Former FDA Commissioner Dr. Scott Gottlieb sits on the boards of Illumina and Pfizer, and he expects more good news–and more secondary benefits–from weight loss drugs on the market. Plus, Michigan is celebrating a big sports weekend, and X is now worth 71.5% less than when Elon Musk bought it, according to Fidelity, one of the co-investors that backed his takeover.
Joe Lieberman - 12:30
Dr. Scott Gottlieb - 24:46
In this episode:
Scott Gottlieb, @ScottGottliebMD
Becky Quick, @BeckyQuick
Robert Frank, @robtfrank
Michael Santoli, @michaelsantoli
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,068 Listeners

3,213 Listeners

1,357 Listeners

240 Listeners

150 Listeners

1,175 Listeners

323 Listeners

67 Listeners

153 Listeners

2,167 Listeners

2,121 Listeners

591 Listeners

20 Listeners

10,015 Listeners

1,567 Listeners

210 Listeners

406 Listeners

302 Listeners

119 Listeners

806 Listeners

59 Listeners

159 Listeners

37 Listeners

14 Listeners

29 Listeners

10 Listeners

16 Listeners